Table 1:
Characteristic and risk factor by Hepatitis C (HCV) status at baseline.
| HCV Negative | HCV Positive | P-value | HCV Negative | HCV Positive | P-value | ||
|---|---|---|---|---|---|---|---|
|
|
|
||||||
| N=594 | N=5 | N=594 | N=5 | ||||
|
|
|
||||||
| Demographic | Substance Use (past 30 days) | ||||||
| Gender | 1.00 | Ecstasy | 1.00 | ||||
| Male to Female | 2 (<1%) | 0 (0%) | No | 450 (76%) | 3 (60%) | ||
| Male | 592 (100%) | 5 (100%) | Yes | 122 (21%) | 0 (0%) | ||
| Race and Ethnicity | 0.38 | Missing | 22 (4%) | 2 (40%) | |||
| White | 306 (52%) | 2 (40%) | Heroin | 1.00 | |||
| African American | 65 (11%) | 2 (40%) | No | 555 (93%) | 3 (60%) | ||
| Hispanic/Latino | 164 (28%) | 1 (20%) | Yes | 15 (3%) | 0 (0%) | ||
| Asian | 23 (4%) | 0 (0%) | Missing | 24 (4%) | 2 (40%) | ||
| Other | 36 (6%) | 0 (0%) | Marijuana | 0.25 | |||
| Education Level | 0.008 | No | 290 (49%) | 3 (60%) | |||
| Highschool or less | 56 (9%) | 3 (60%) | Yes | 282 (47%) | 0 (0%) | ||
| Some college or more | 538 (91%) | 2 (40%) | Missing | 22 (4%) | 2 (40%) | ||
| Age at enrollment, mean (SD) | 38 (10) | 51 (5) | 0.002 | Methamphetamines | 0.071 | ||
| Sexually Transmitted Infections | No | 480 (81%) | 1 (20%) | ||||
| Hepatitis B | 1.00 | Yes | 92 (15%) | 2 (40%) | |||
| Negative | 534 (90%) | 5 (100%) | Missing | 22 (4%) | 2 (40%) | ||
| Positive | 2 (<1%) | 0 (0%) | Hallucinogens | 1.00 | |||
| Missing | 58 (10%) | 0 (0%) | No | 532 (90%) | 3 (60%) | ||
| Any Gonorrhea | 1.00 | Yes | 39 (7%) | 0 (0%) | |||
| Negative | 267 (45%) | 3 (60%) | Missing | 23 (4%) | 2 (40%) | ||
| Positive | 58 (10%) | 0 (0%) | Dissociative | 1.00 | |||
| Missing | 269 (45%) | 2 (40%) | No | 541 (91%) | 3 (60%) | ||
| Any Chlamydia | 1.00 | Yes | 32 (5%) | 0 (0%) | |||
| Negative | 269 (45%) | 3 (60%) | Missing | 21 (4%) | 2 (40%) | ||
| Positive | 58 (10%) | 0 (0%) | Popper | 0.61 | |||
| Missing | 267 (45%) | 2 (40%) | No | 273 (46%) | 2 (40%) | ||
| Syphilis | 0.78 | Yes | 300 (51%) | 1 (20%) | |||
| Negative | 269 (45%) | 3 (60%) | Missing | 21 (4%) | 2 (40%) | ||
| Positive | 43 (97%) | 0 (0%) | Cocaine | 1.00 | |||
| Missing | 282 (48%) | 2 (40%) | No | 464 (78%) | 3 (60%) | ||
| Yes | 109 (18%) | 0 (0%) | |||||
| Missing | 21 (4%) | 2 (40%) | |||||
| Sexual Risk Behavior (past 30 days) | PrEP Adherence | ||||||
| Anal sex in past 30 days | 1.00 | Mean PrEP Adherence | 0.029 | ||||
| No | 11 (2%) | 0 (0%) | Not adequate/below quantification | 80 (13%) | 2 (40%) | ||
| Yes | 563 (95%) | 3 (60%) | Adequate/Protective | 267 (45%) | 0 (0%) | ||
| Missing | 20 (3%) | 2 (40%) | Perfect | 223 (38%) | 2 (40%) | ||
| No. male partners for anal sex, median (IQR) | 5 (3, 10) | 3.5 (3, 4) | 0.39 | Missing | 24 (4%) | 1 (20%) | |
| No. unprotected ARS, median (IQR) | 1 (0, 3.5) | 4.5 (1, 8) | 0.34 | ||||
| No. unprotected AIS, median (IQR) | 2 (0, 4) | 1 (1, 1) | 0.60 | ||||
| No. HIV negative partners, median (IQR) | 1 (0, 3) | 1 (0, 2) | 0.68 | ||||
NOTES:
Percentages are column totals
P-value is for Fisher’s Exact Test and Wilcoxon Rank Sum/T-Test
Any Gonorrhea: any of rectal, urine and/or pharyngeal cases; Any Chlamydia: any of rectal and/or urine cases
ARS/AIS: Anal receptive sex/Anal insertive sex
Mean PrEP adherence is mean value measured at week 12 and last study visit